Valneva SE (VALN) Form 10-Q Quarterly Reports
Valneva SE (VALN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VALN
CIK: 1836564
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: I0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Associés
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJean-Baptiste Barras
Audit LocationParis-La Défense, France
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-15 | 2026-12-31 | 6-K | 0001628280-26-065954 | View SEC Doc Filr Page |
| 6-K | 2026-10-08 | 2026-12-31 | 6-K | 0001628280-26-065400 | View SEC Doc Filr Page |
| 6-K | 2026-08-14 | 2026-12-31 | 6-K | 0001628280-26-056999 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-06-30 | 6-K | 0001628280-26-056525 | View SEC Doc Filr Page |
| 6-K | 2026-07-22 | 2026-12-31 | 6-K | 0001628280-26-049149 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-12-31 | 6-K | 0001628280-26-045398 | View SEC Doc Filr Page |
| EFFECT | 2026-06-16 | — | EFFECT Filing | 9999999995-26-002019 | View SEC Doc Filr Page |
| 424B3 | 2026-06-16 | — | PROSPECTUS | 0001999371-26-012935 | View SEC Doc Filr Page |
| CORRESP | 2026-06-12 | — | CORRESP Filing | 0001999371-26-012760 | View SEC Doc Filr Page |
| UPLOAD | 2026-06-11 | — | UPLOAD Filing | 0000000000-26-005889 | View SEC Doc Filr Page |
| 6-K | 2026-06-05 | 2026-12-31 | 6-K | 0001628280-26-041033 | View SEC Doc Filr Page |
| F-3 | 2026-06-04 | — | REGISTRATION STATEMENT FOR SPECIFIED TRANSACTIONS BY CERTAIN FOREIGN PRIVATE ISS | 0001999371-26-012100 | View SEC Doc Filr Page |
| 6-K | 2026-06-01 | 2026-12-31 | 6-K | 0001628280-26-039308 | View SEC Doc Filr Page |
| 6-K | 2026-05-13 | 2026-03-31 | 6-K | 0001628280-26-034662 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-12 | — | SCHEDULE 13D/A Filing | 0001104659-26-059496 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-12 | — | SCHEDULE 13G Filing | 0001231919-26-000483 | View SEC Doc Filr Page |
| 6-K | 2026-05-05 | 2026-12-31 | 6-K | 0001628280-26-030265 | View SEC Doc Filr Page |
| 6-K | 2026-04-30 | 2026-12-31 | 6-K | 0001628280-26-029000 | View SEC Doc Filr Page |
| 6-K | 2026-03-26 | 2026-12-31 | 6-K | 0001628280-26-021321 | View SEC Doc Filr Page |
| 6-K | 2026-03-23 | 2026-12-31 | 6-K | 0001628280-26-020495 | View SEC Doc Filr Page |
| 6-K | 2026-03-18 | 2026-12-31 | 6-K | 0001628280-26-019159 | View SEC Doc Filr Page |
| 20-F | 2026-03-17 | 2025-12-31 | 20-F | 0001628280-26-018808 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-03-10 | — | SCHEDULE 13D/A Filing | 0001104659-26-025806 | View SEC Doc Filr Page |
| 6-K | 2026-03-09 | 2026-12-31 | 6-K | 0001628280-26-015882 | View SEC Doc Filr Page |
| 6-K | 2026-03-02 | 2026-12-31 | 6-K | 0001628280-26-013074 | View SEC Doc Filr Page |